Search research articles
Contact Us
Filters
Showing results (161-170 of 173) with videos related to
Page
of 18
Sort By:
Cell Discovery
|
September 8, 2022
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages
Xiaoman Li, Yongbing Pan, Qiangling Yin, et al.
BMC Medicine
|
June 6, 2025
Intraoperatively preventive intraperitoneal perfusion chemotherapy with lobaplatin in colorectal cancer: a prospective, randomised, controlled, multicentre study
Hao Su, Rui Zhang, Yunfeng Li, et al.
Antiviral Research
|
March 5, 2023
Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
Changrui Lu, Yuntao Zhang, Xiaohu Liu, et al.
Nature Communications
|
August 6, 2021
Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
Cesheng Li, Ding Yu, Xiao Wu, et al.
JAMA
|
August 14, 2020
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials
Shengli Xia, Kai Duan, Yuntao Zhang, et al.
Nature Communications
|
July 7, 2021
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
Cesheng Li, Ding Yu, Xiao Wu, et al.
Frontiers in Immunology
|
July 11, 2022
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial
Shengli Xia, Kai Duan, Yuntao Zhang, et al.
Eclinicalmedicine
|
July 12, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial
Wanshen Guo, Kai Duan, Yuntao Zhang, et al.
Cell Discovery
|
December 9, 2022
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
Hong Liang, Xuanxuan Nian, Junzheng Wu, et al.
Science Bulletin
|
December 22, 2022
Short-term and oncological outcomes of natural orifice specimen extraction surgery (NOSES) for colorectal cancer in China: a national database study of 5055 patients
Xu Guan, Xiyue Hu, Zheng Jiang, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 173) with videos related to
Sort By:
Page
of 18
Cell Discovery
|
September 8, 2022
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages
Xiaoman Li, Yongbing Pan, Qiangling Yin, et al.
BMC Medicine
|
June 6, 2025
Intraoperatively preventive intraperitoneal perfusion chemotherapy with lobaplatin in colorectal cancer: a prospective, randomised, controlled, multicentre study
Hao Su, Rui Zhang, Yunfeng Li, et al.
Antiviral Research
|
March 5, 2023
Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine
Changrui Lu, Yuntao Zhang, Xiaohu Liu, et al.
Nature Communications
|
August 6, 2021
Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
Cesheng Li, Ding Yu, Xiao Wu, et al.
JAMA
|
August 14, 2020
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials
Shengli Xia, Kai Duan, Yuntao Zhang, et al.
Nature Communications
|
July 7, 2021
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
Cesheng Li, Ding Yu, Xiao Wu, et al.
Frontiers in Immunology
|
July 11, 2022
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial
Shengli Xia, Kai Duan, Yuntao Zhang, et al.
Eclinicalmedicine
|
July 12, 2021
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial
Wanshen Guo, Kai Duan, Yuntao Zhang, et al.
Cell Discovery
|
December 9, 2022
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
Hong Liang, Xuanxuan Nian, Junzheng Wu, et al.
Science Bulletin
|
December 22, 2022
Short-term and oncological outcomes of natural orifice specimen extraction surgery (NOSES) for colorectal cancer in China: a national database study of 5055 patients
Xu Guan, Xiyue Hu, Zheng Jiang, et al.
Page
of 18